107 related articles for article (PubMed ID: 8058164)
1. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis.
Rieckmann P; Albrecht M; Kitze B; Weber T; Tumani H; Broocks A; Lüer W; Poser S
Neurology; 1994 Aug; 44(8):1523-6. PubMed ID: 8058164
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.
Rieckmann P; Albrecht M; Kitze B; Weber T; Tumani H; Broocks A; Lüer W; Helwig A; Poser S
Ann Neurol; 1995 Jan; 37(1):82-8. PubMed ID: 7818262
[TBL] [Abstract][Full Text] [Related]
3. Cytokine mRNA expression in CSF and peripheral blood mononuclear cells in multiple sclerosis: detection by RT-PCR without in vitro stimulation.
Monteyne P; Van Laere V; Marichal R; Sindic CJ
J Neuroimmunol; 1997 Dec; 80(1-2):137-42. PubMed ID: 9413269
[TBL] [Abstract][Full Text] [Related]
4. Expression of TNF-alpha mRNA by peripheral blood mononuclear cells of multiple sclerosis patients treated with IFN-beta 1A.
Sarchielli P; Critelli A; Greco L; Sokola E; Floridi A; Gallai V
Cytokine; 2001 Jun; 14(5):294-8. PubMed ID: 11444910
[TBL] [Abstract][Full Text] [Related]
5. Data on cytokine mRNA expression in CSF and peripheral blood mononuclear cells from MS patients as detected by PCR.
Monteyne P; Sindic CJ
Mult Scler; 1998 Jun; 4(3):143-6. PubMed ID: 9762664
[TBL] [Abstract][Full Text] [Related]
6. [IL-2, IFN-gamma, and TNF-alpha mRNA expression in peripheral blood mononuclear cells in patients with multiple sclerosis].
Lin J; Li L; Gao Y; Min B; Xu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Feb; 19(1):24-8. PubMed ID: 10453548
[TBL] [Abstract][Full Text] [Related]
7. Serial analysis of cytokine mRNA profiles in whole blood samples from patients with early multiple sclerosis.
Kahl KG; Kruse N; Toyka KV; Rieckmann P
J Neurol Sci; 2002 Aug; 200(1-2):53-5. PubMed ID: 12127676
[TBL] [Abstract][Full Text] [Related]
8. Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease.
Söderström M; Hillert J; Link J; Navikas V; Fredrikson S; Link H
Mult Scler; 1995 Nov; 1(3):173-80. PubMed ID: 9345450
[TBL] [Abstract][Full Text] [Related]
9. Expression of costimulatory molecules and cytokines in CSF and peripheral blood mononuclear cells from multiple sclerosis patients.
Monteyne P; Van Antwerpen MP; Sindic CJ
Acta Neurol Belg; 1999 Mar; 99(1):11-20. PubMed ID: 10218088
[TBL] [Abstract][Full Text] [Related]
10. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
[TBL] [Abstract][Full Text] [Related]
11. TRPM4 mRNA expression levels in peripheral blood mononuclear cells from multiple sclerosis patients.
Malhotra S; Castilló J; Negrotto L; Merino-Zamorano C; Montaner J; Vidal-Jordana A; Montalban X; Comabella M
J Neuroimmunol; 2013 Aug; 261(1-2):146-8. PubMed ID: 23796873
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of IL-15 mRNA in relapsing--remitting multiple sclerosis attacks.
Blanco-Jerez C; Plaza JF; Masjuan J; Orensanz LM; Alvarez-Cermeño JC
J Neuroimmunol; 2002 Jul; 128(1-2):90-4. PubMed ID: 12098515
[TBL] [Abstract][Full Text] [Related]
13. Effect of cryopreservation on expression of Th1 and Th2 cytokines in blood mononuclear cells from patients with different cytokine profiles, analysed with three common assays: an overall decrease of interleukin-4.
Kvarnström M; Jenmalm MC; Ekerfelt C
Cryobiology; 2004 Oct; 49(2):157-68. PubMed ID: 15351687
[TBL] [Abstract][Full Text] [Related]
14. Prior poliomyelitis-evidence of cytokine production in the central nervous system.
Gonzalez H; Khademi M; Andersson M; Wallström E; Borg K; Olsson T
J Neurol Sci; 2002 Dec; 205(1):9-13. PubMed ID: 12409177
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients.
Bertolotto A; Capobianco M; Malucchi S; Manzardo E; Audano L; Bergui M; Bradac GB; Mutani R
Neurosci Lett; 1999 Mar; 263(1):21-4. PubMed ID: 10218901
[TBL] [Abstract][Full Text] [Related]
17. Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients.
Lagoo AS; George JF; Naftel DC; Griffin AK; Kirklin JK; Lagoo-Deenadayalan S; Hardy KJ; Savunen T; McGiffin DC
J Heart Lung Transplant; 1996 Feb; 15(2):206-17. PubMed ID: 8672525
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroids induce expression of transforming-growth-factor-beta1 mRNA in peripheral blood mononuclear cells of patients with multiple sclerosis.
Ossege LM; Sindern E; Voss B; Malin JP
J Neuroimmunol; 1998 Apr; 84(1):1-6. PubMed ID: 9600702
[TBL] [Abstract][Full Text] [Related]
19. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Bornstein NM; Karni A
J Neuroimmunol; 2011 Mar; 232(1-2):171-8. PubMed ID: 21111488
[TBL] [Abstract][Full Text] [Related]
20. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity.
Carrieri PB; Provitera V; De Rosa T; Tartaglia G; Gorga F; Perrella O
Immunopharmacol Immunotoxicol; 1998 Aug; 20(3):373-82. PubMed ID: 9736442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
